For instance, T-cell membranes engineered with a chimeric antigen receptor (CAR) targeting HER2 or engineered with CD80 have been utilized to coat nanoparticles for cancer treatment, achieving the successful delivery of anticancer agents and fostering anticancer immunity [35,69]. This evidence concerns the gene ERBB2 and cancer.